Suppr超能文献

利用铽放射性同位素推动临床进展:一项系统综述。

Harnessing Terbium Radioisotopes for Clinical Advancements: A Systematic Review.

作者信息

Abdlkadir Ahmed Saad, Rosar Florian, Jalilian Amireza, Moghrabi Serin, Al-Balooshi Batool, Rabei Obayda, Kairemo Kalevi, Al-Ibraheem Akram

机构信息

Department of Nuclear Medicine, King Hussein Cancer Center (KHCC), Queen Rania Street, Al Jubeiha, Amman, 11942 Jordan.

Department of Nuclear Medicine, Saarland University - Medical Center, 66123 Homburg, Germany.

出版信息

Nucl Med Mol Imaging. 2025 Feb;59(1):50-61. doi: 10.1007/s13139-024-00891-0. Epub 2024 Nov 12.

Abstract

Background this systematic review was conducted to assess the practical application of terbium radioisotopes, utilizing systematic search methodologies to identify relevant studies. Methods the databases of PubMed, Web of Science, and Scopus were systematically scoured, targeting the research on four terbium isotopes:  Tb,  Tb,  Tb, and  Tb. Various combinations of keywords related to terbium and its four radioisotopes were used in the search process. The search encompassed studies conducted up to July 27, 2024. Results following the removal of 335 duplicate research articles, a cohort of 429 papers was curated for potential inclusion in the study. Out of 429 articles reviewed, a mere nine addressed the potential uses of  Tb and  Tb. Notably,  Tb and  Tb have yet to be examined in human subjects. Conclusions the research trajectory is now veering towards clinical studies that provide in-human data, with the goal of advancing radiotheranostics and nuclear oncology. The preliminary outcomes are stimulating and have led to the initiation of several clinical trials. The success of these trials and the establishment of production facilities will be critical for the clinical adoption of these agents.

摘要

背景

本系统评价旨在评估铽放射性同位素的实际应用,采用系统检索方法来识别相关研究。方法:系统检索了PubMed、科学网和Scopus数据库,针对四种铽同位素(Tb、Tb、Tb和Tb)的研究。在检索过程中使用了与铽及其四种放射性同位素相关的各种关键词组合。检索涵盖截至2024年7月27日进行的研究。结果:在剔除335篇重复研究文章后,筛选出429篇论文以供可能纳入该研究。在审查的429篇文章中,仅有9篇涉及Tb和Tb的潜在用途。值得注意的是,Tb和Tb尚未在人体受试者中进行研究。结论:研究方向目前正转向提供人体数据的临床研究,目标是推进放射治疗诊断学和核肿瘤学。初步结果令人鼓舞,并已启动了多项临床试验。这些试验的成功以及生产设施的建立对于这些药物的临床应用至关重要。

相似文献

8
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.

本文引用的文献

4
Radiotheranostics Global Market and Future Developments.放射性药物全球市场与未来发展。
Semin Nucl Med. 2024 Jul;54(4):622-633. doi: 10.1053/j.semnuclmed.2024.02.003. Epub 2024 Mar 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验